Throughout the Fall 2018 semester, scientists from the Drug Discovery and Drug Development divisions within the pharmaceutical company Bristol-Myers Squibb teach the regulatory approval of safe medications to improve human health. Each week, students and postdocs from the toxicology and other biomedical graduate programs learn about experimental design, risk assessment, and product development through lectures and case studies.
